๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

De novo diffuse large B-cell lymphoma with coexpression of CD5 and CD23

โœ Scribed by Sumeet Gujral; Meenal Jain; Kiran Thorat; Dipen Maru; Chandrika N. Nair

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
241 KB
Volume
82
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The therapeutic effect of rituximab on C
The therapeutic effect of rituximab on CD5-positive and CD5-negative diffuse large B-cell lymphoma
โœ Rie Hyo; Naoto Tomita; Kengo Takeuchi; Tomohiro Aoshima; Atsuko Fujita; Hideyuki ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 111 KB

## Abstract The prognosis of diffuse large Bโ€cell lymphoma (DLBCL) has improved markedly in recent years of rituximab era. The prognosis of __de novo__ CD5โ€positive DLBCL is reported to be poor, but the effect of rituximab on this type of lymphoma remains unclear. To investigate the effect of ritux

Analysis of chromosomal imbalances in de
Analysis of chromosomal imbalances in de novo CD5-positive diffuse large-B-cell lymphoma detected by comparative genomic hybridization
โœ Sivasundaram Karnan; Hiroyuki Tagawa; Ritsuro Suzuki; Miyuki Suguro; Motoko Yama ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 107 KB

We recently demonstrated that the prognosis for de novo CD5-positive (CD5+) diffuse large-B-cell lymphoma (DLBCL) is markedly worse than that for CD5-negative (CD5-) DLBCL. Our findings also suggested that on the basis of its clinical features CD5+ DLBCL may constitute a unique disease category. How

Vav-1 expression correlates with NFฮบB ac
Vav-1 expression correlates with NFฮบB activation and CD40-mediated cell death in diffuse large B-cell lymphoma cell lines
โœ Annette Hollmann; Raquel Aloyz; Kristi Baker; Stephan Dirnhofer; Trevor Owens; R ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 439 KB

## Abstract Diffuse large Bโ€cell lymphoma (DLBCL) is an aggressive malignancy with a variable response to therapy. We have previously shown that DLBCL cell lines differ in their susceptibility to CD40โ€mediated cell death, and that resistance to CD40โ€targeted antibodies correlated with increased exp

Cytogenetic features of de novo CD5-posi
Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: Chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival
โœ Tomoko Yoshioka; Ikuo Miura; Masaaki Kume; Naoto Takahashi; Masataka Okamoto; Ry ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 257 KB

## Abstract De novo CD5โ€positive diffuse large Bโ€cell lymphoma (CD5^+^DLBCL) is regarded as a different clinicopathological entity from CD5โ€negative DLBCL (CD5^โˆ’^DLBCL) and mantle cell lymphoma (MCL). Because only a few published cytogenetic studies of de novo CD5^+^DLBCL are available, we investig